ACER

ACER Stock Price Increases Over 30% Pre-Market: Why It Happened

ACER Stock: The Merger Rumor That Has Acer Therapeutics Racing Higher

ACER Stock Price Increases Over 100% Pre-Market: What You Should Know About The Company

Acer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

Acer Therapeutics Announces Topline Results from its Bioequivalence Trial of ACER-001 Compared to BUPHENYL® Under Fed Conditions

Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease